Evolution of the Average Target: Alaunos Therapeutics, Inc.

Evolution of the Average Target - Alaunos Therapeutics, Inc.

Evolution of the Target Price: Alaunos Therapeutics, Inc.

Evolution of the Target Price - Alaunos Therapeutics, Inc.

Changes in Analyst Recommendations: Alaunos Therapeutics, Inc.

0e209cc4175778128cec6ba524.Gfx3qvYxIQY_KTrAANOYa9MKSkYxhlTOjrBk5iOBdkk.aKQN-cZwckt8Z1eOWbTSAqI8LiVDwiWE6IFX1GLIFH8tuC__jmZJRFYEWQ~26a2a3d35657ab3b6776c0d824511d69

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+43.71%
+19.51%
+11.58%
+20.93%
+26.88%
+30.99%
+70.4%
+20.93%
+37.4%
Average +31.37%
Weighted average by Cap. +30.28%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.660
Average target price
-

Analyst Consensus Detail

Analyst consensus - Alaunos Therapeutics, Inc.

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Alaunos Therapeutics, Inc.
  1. Stock Market
  2. Stocks
  3. TCRT Stock
  4. Consensus Alaunos Therapeutics, Inc.